Lv41
716 积分 2022-06-06 加入
First-in-human study on tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of XKH001, a recombinant humanized monoclonal antibody against IL-25 in healthy Chinese volunteers
6天前
已完结
Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis
1个月前
已完结
Novel asthma treatments: Advancing Beyond Approved Novel Step-Up Therapies for Asthma
2个月前
已完结
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
IL-33/ST2 axis in autoimmune disease
4个月前
已完结
Inflammasomes: emerging therapeutic targets in hidradenitis suppurativa?
4个月前
已完结
Interleukin‐25 recognition by its unique receptor IL‐17Rb via two discrete linear and cyclic epitopes
4个月前
已完结
Interleukin‐25 recognition by its unique receptor IL‐17Rb via two discrete linear and cyclic epitopes
4个月前
已关闭
Interleukin‐25 recognition by its unique receptor IL‐17Rb via two discrete linear and cyclic epitopes
4个月前
已关闭
Evidence from recent clinical trials in fibrotic interstitial lung diseases
4个月前
已完结
皖公网安备34019202002308
